VERDI: SARS-coV2 variants Evaluation in pRegnancy and paeDIatrics cohorts
INSTITUTE OF HUMAN VIROLOGY NIGERIA LTDGTE
participó en un
HORIZON EUROPE:
HORIZON-HLTH-2021-CORONA-01
Variants of concern (VoC) of SARS-CoV-2 raise the possibility of increases in transmissibility, severity and immune evasion. Children and pr...
2021-11-11 - 2025-10-31 | Financiado
2021-11-11 - 2025-10-31 | Financiado
B3Africa: Bridging Biobanking and Biomedical Research across Europe and Africa
INSTITUTE OF HUMAN VIROLOGY NIGERIA LTDGTE
participó en un
H2020:
H2020-INFRASUPP-2014-2015
B3Africa - Bridging Biobanking and Biomedical Research across Europe and Africa will dramatically improve and facilitate the development of...
2015-06-02 - 2018-09-30 | Financiado
2015-06-02 - 2018-09-30 | Financiado
* No se disponen de datos de la empresa actual.